Showing results (961-970 of 12,114) with videos related to
Sort By:
Pageof 1,212
Neuropharmacology|June 23, 2018
Novel therapies for combating chronic neuropathological sequelae of TBIMilos D Ikonomovic, Eric E Abrahamson, Shaun W Carlson, et al.Neuropharmacology|June 25, 2018
Prophylactic vaccination protects against the development of oxycodone self-administrationJacques D Nguyen, Candy S Hwang, Yanabel Grant, et al.Neuropharmacology|June 25, 2018
Behavioral and cellular dopamine D1 and D3 receptor-mediated synergy: Implications for L-DOPA-induced dyskinesiaKathryn Lanza, Samantha M Meadows, Nicole E Chambers, et al.Neuropharmacology|July 1, 2018
Chronic stress dysregulates amygdalar output to the prefrontal cortexEmily G Lowery-Gionta, Nicole A Crowley, Olena Bukalo, et al.Neuropharmacology|July 17, 2018
Anti-cancer and analgesic effects of resolvin D2 in oral squamous cell carcinomaYi Ye, Nicole N Scheff, Daniel Bernabé, et al.Neuropharmacology|July 17, 2018
Aiming for the target: Mitochondrial drug delivery in traumatic brain injuryAndrew M Lamade, Elizabeth M Kenny, Tamil S Anthonymuthu, et al.Neuropharmacology|August 31, 2018
High frequency stimulation-induced plasticity in the prelimbic cortex of rats emerges during adolescent development and is associated with an increase in dopamine receptor functionShuo Kang, Charles L Cox, Joshua M GulleyNeuropharmacology|May 31, 2019
Modulation of LPA1 receptor-mediated neuronal apoptosis by Saikosaponin-d: A target involved in depressionLixing Xu, Jing Su, Liting Guo, et al.Neuropharmacology|June 3, 2019
The effect of pyruvate on the development and progression of post-stroke depression: A new therapeutic approachDmitry Frank, Ruslan Kuts, Philip Tsenter, et al.Neuropharmacology|June 2, 2019
Brain insulin action: Implications for the treatment of schizophreniaSri Mahavir Agarwal, Chantel Kowalchuk, Laura Castellani, et al.Pageof 1,212